Robin joined 3i in 2000 and has worked on Venture Capital, Growth and Buyout deals. Prior to founding 3i’s US Growth Capital business, Robin was a Managing Director in 3i’s UK operation. Since January 2006, Robin has been a Partner in 3i's US Growth Capital business based in New York.

Over his investing career, Robin has been involved in investments in Quintiles, Ben Sherman, Careshare, Ardana Bioscience, Canvas Holidays, Local Press, Epcon Offshore, GAIN Capital, Fulcrum and Petrochem Carless. Prior to joining 3i, Robin was with Procter & Gamble and McKinsey & Company.

Robin currently serves on the Board of Directors of Quintiles and ACG (Association for Corporate Growth).

Robin graduated from the University of Glasgow, and was a Post Graduate Thouron Fellow at the University of Pennsylvania.